Cargando…
Novel pharmacological approaches in abdominal aortic aneurysm
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health issue with an unmet medical need for therapy. This disease is featured by a progressive dilation of the abdominal aorta, boosted by atherosclerosis, ageing, and smoking as major risk factors. Aneurysm growth incre...
Autores principales: | Puertas-Umbert, Lídia, Almendra-Pegueros, Rafael, Jiménez-Altayó, Francesc, Sirvent, Marc, Galán, María, Martínez-González, José, Rodríguez, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415166/ https://www.ncbi.nlm.nih.gov/pubmed/37559446 http://dx.doi.org/10.1042/CS20220795 |
Ejemplares similares
-
Colchicine protects against the development of experimental abdominal aortic aneurysm
por: Zhao, Yi, et al.
Publicado: (2023) -
Role of prostaglandin D(2) receptors in the pathogenesis of abdominal aortic aneurysm formation
por: Weintraub, Neal L., et al.
Publicado: (2022) -
ANGPTL8 deletion attenuates abdominal aortic aneurysm formation in ApoE(−/−) mice
por: Yu, Huahui, et al.
Publicado: (2023) -
Inhibition of smooth muscle cell death by Angiotensin 1-7 protects against abdominal aortic aneurysm
por: Jadli, Anshul S., et al.
Publicado: (2023) -
Vitamin D deficiency promotes large rupture-prone abdominal aortic aneurysms and cholecalciferol supplementation limits progression of aneurysms in a mouse model
por: Nsengiyumva, Vianne, et al.
Publicado: (2020)